Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yuji Yoshida, Yuko Takahashi, Nobuyoshi Minemura, Yo Ueda, Hiroyuki Yamashita, Hiroshi Kaneko & Akio Mimori. (2012) Prognosis of pneumocystis pneumonia complicated in patients with rheumatoid arthritis (RA) and non-RA rheumatic diseases. Modern Rheumatology 22:4, pages 509-514.
Read now
Read now
Jennifer Lucas, Edidiong Ntuen, Daniel J. Pearce, Alan B. Fleischer$suffix/text()$suffix/text() & Steven R. Feldman. (2009) Methotrexate: Understanding the risk in psoriasis patients. Journal of Dermatological Treatment 20:5, pages 311-313.
Read now
Read now
Yuko Kaneko, Akira Suwa, Yasuo Ikeda & Michito Hirakata. (2006) Pneumocystis jiroveci pneumonia associated with low-dose methotrexate treatment for rheumatoid arthritis: report of two cases and review of the literature. Modern Rheumatology 16:1, pages 36-38.
Read now
Read now
F Roblot. (2005) Management of Pneumocystis pneumonia in patients with inflammatory disorders. Expert Review of Anti-infective Therapy 3:3, pages 435-444.
Read now
Read now
Articles from other publishers (31)
Takahiro Nunokawa, Naofumi Chinen, Kota Shimada, Makiko Kimura, Mutsuto Tateishi, Fang Yi Chen, Keigo Setoguchi & Makoto Sugihara. (2023) Efficacy of sulfasalazine for the prevention of Pneumocystis pneumonia in patients with rheumatoid arthritis: A multicentric self-controlled case series study. Journal of Infection and Chemotherapy 29:2, pages 193-197.
Crossref
Crossref
Shin-ichiro Ohmura, Yoichiro Homma, Takayuki Masui & Toshiaki Miyamoto. (2022) Factors Associated with <i>Pneumocystis jirovecii</i> Pneumonia in Patients with Rheumatoid Arthritis Receiving Methotrexate: A Single-center Retrospective Study. Internal Medicine 61:7, pages 997-1006.
Crossref
Crossref
Romain Lécuyer, Nahema Issa, Benoit Tessoulin, Rose-Anne Lavergne, Florent Morio, Frederic Gabriel, Emmanuel Canet, Céline Bressollette-Bodin, Aurélie Guillouzouic, David Boutoille, François Raffi, Raphael Lecomte, Paul Le Turnier, Colin Deschanvres, Fabrice Camou, Benjamin Jean Gaborit, Francois Raffi, David Boutoille, Charlotte Biron, Maeva Lefebvre, Benjamin Jean Gaborit, Paul Le Turnier, Colin Deschanvres, Raphael Lecomte, Marie Chauveau, Romain Lécuyer, Antoine Asquier-Khati, Patrice Le Pape, Florent Morio, Rose-Anne Lavergne, Fakhri Jeddi, Stéphane Corvec, Pascale Bemer, Jocelyne Caillon, Aurélie Guillouzouic, Anne-Gaëlle Leroy, Karim Lakhal, Raphaël Cinotti, Antoine Roquilly, Karim Asehnoune, Jean Reignier, Emmanuel Canet, Olivier Zambon, Amélie Seguin, Arnaud-Félix Miailhe, François Xavier Blanc, Cédric Bretonniere, Paul Morin, Fabrice Camou, Nahéma Issa, Olivier Guisset, Gaelle Mourissoux, Laurence Delhaes, Isabelle Accoceberry & Frederic Gabriel. (2022)
Epidemiology and Clinical Impact of Respiratory Coinfections at Diagnosis of
Pneumocystis jirovecii
Pneumonia
. The Journal of Infectious Diseases 225:5, pages 868-880.
Crossref
Crossref
I. W. FongI. W. Fong. 2020. Current Trends and Concerns in Infectious Diseases. Current Trends and Concerns in Infectious Diseases
131
163
.
Takahiro Nunokawa, Naoto Yokogawa, Kota Shimada, Shoji Sugii, Jinju Nishino, Masahiko Gosho, Yukiko Wagatsuma & Shigeto Tohma. (2019) Prophylactic effect of sulfasalazine against Pneumocystis pneumonia in patients with rheumatoid arthritis: A nested case-control study. Seminars in Arthritis and Rheumatism 48:4, pages 573-578.
Crossref
Crossref
M.-A. Cornetto & A. Bergeron. (2018) Cas clinique n° 6 : Infection pulmonaire au cours d’une maladie de système. Revue des Maladies Respiratoires Actualités 10:1, pages 46-52.
Crossref
Crossref
Sally J. Lawrence, Manish Sadarangani & Kevan Jacobson. (2017) Pneumocystis jirovecii Pneumonia in Pediatric Inflammatory Bowel Disease: A Case Report and Literature Review. Frontiers in Pediatrics 5.
Crossref
Crossref
Noboru Takayanagi,. (2015) Biological agents and respiratory infections: Causative mechanisms and practice management. Respiratory Investigation 53:5, pages 185-200.
Crossref
Crossref
Shunsuke MoriMineharu Sugimoto. (2015)
Pneumocystis Jirovecii
Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations
. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 9s1, pages CCRPM.S23286.
Crossref
Crossref
S. Mori & M. Sugimoto. (2012) Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis. Rheumatology 51:12, pages 2120-2130.
Crossref
Crossref
D. Meyer-Olson, K. Hoeper & R.E. Schmidt. (2010) Infektionskomplikationen unter Biologika-Therapie bei Patienten mit rheumatoider ArthritisInfectious complications of biologic therapy in patients with rheumatoid arthritis. Zeitschrift für Rheumatologie 69:10, pages 879-888.
Crossref
Crossref
DEANNA CETTOMAI, ALLAN C. GELBER & LISA CHRISTOPHER-STINE. (2010) A Survey of Rheumatologists’ Practice for Prescribing Pneumocystis Prophylaxis. The Journal of Rheumatology 37:4, pages 792-799.
Crossref
Crossref
Parbeer Grewal & Alain Brassard. (2009)
Fact or Fiction: Does the Non-HIV/AIDS: Immunosuppressed Patient Need
Pneumocystis Jiroveci
Pneumonia Prophylaxis? An Updated Literature Review
. Journal of Cutaneous Medicine and Surgery 13:6, pages 308-312.
Crossref
Crossref
Lesley Ann Saketkoo & Luis R. Espinoza. 2009. Infectious Diseases in Critical Care Medicine. Infectious Diseases in Critical Care Medicine
376
386
.
Lesley Ann Saketkoo & Luis R. Espinoza. 2009. Infectious Diseases in Critical Care Medicine. Infectious Diseases in Critical Care Medicine
376
386
.
J.F. Rahier, S. Ben-Horin, Y. Chowers, C. Conlon, P. De Munter, G. D'Haens, E. Domènech, R. Eliakim, A. Eser, J. Frater, M. Gassull, M. Giladi, A. Kaser, M. Lémann, T. Moreels, A. Moschen, R. Pollok, W. Reinisch, M. Schunter, E.F. Stange, H. Tilg, G. Van Assche, N. Viget, B. Vucelic, A. Walsh, G. Weiss, Y. Yazdanpanah, Y. Zabana, S.P.L. Travis & J.F. Colombel. (2009) European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. Journal of Crohn's and Colitis 3:2, pages 47-91.
Crossref
Crossref
Mehdi Khellaf & Bertrand Godeau. (2009) Pneumocystose au cours des maladies systémiques. La Presse Médicale 38:2, pages 251-259.
Crossref
Crossref
N. De Castro, J. Pavie, M. Lagrange-Xélot & J.M. Molina. (2007) Pneumocystose chez les patients d’onco-hématologie : est-ce inévitable ?. Revue des Maladies Respiratoires 24:6, pages 741-750.
Crossref
Crossref
Lesley Ann Saketkoo & Luis R. Espinoza. (2006) Impact of Biologic Agents on Infectious Diseases. Infectious Disease Clinics of North America 20:4, pages 931-961.
Crossref
Crossref
B. Bertisch & C. Ruef. (2006) Pneumocystis-jiroveci-Pneumonie (PcP) bei Patienten mit rheumatologischen Erkrankungen: Fallbeschreibung und ReviewPneumocystis jiroveci pneumonia (PcP) in patients with rheumatic diseases: case report and review. Zeitschrift für Rheumatologie 65:1, pages 18-23.
Crossref
Crossref
M. Mariñosa, A. Soler, X. Nogués & J. Pedro-Botet. (2004) Pulmonary coinfection by Pneumocystis carinii and Aspergillus fumigatus in a seronegative arthritis patient treated with low-dose methotrexate. Clinical Rheumatology 23:6, pages 555-556.
Crossref
Crossref
Julie K. Dawson, Adrian R. Clewes & Julie Hendry. (2004) Pulmonary Effects of Low-Dose Methotrexate Therapy. Clinical Pulmonary Medicine 11:5, pages 307-317.
Crossref
Crossref
Robert Vassallo & Charles F Thomas. (2004) Advances in the treatment of rheumatic interstitial lung disease. Current Opinion in Rheumatology 16:3, pages 186-191.
Crossref
Crossref
I. TheateL. Michaux, S. DardenneY. GuiotJ. BrièreF.J. EmileB. FabianiR. DetryP. Gaulard. (2002) Epstein–Barr virus‐associated lymphoproliferative disease occurring in a patient with sarcoidosis treated by methotrexate and methylprednisolone. European Journal of Haematology 69:4, pages 248-253.
Crossref
Crossref
Graciela S Alarcón. (2000) Methotrexate use in rheumatoid arthritis. A clinician's perspective. Immunopharmacology 47:2-3, pages 259-271.
Crossref
Crossref
Graciela S. Alarcón & Sarah L. Morgan. 2000. Methotrexate. Methotrexate
83
108
.
Katherine E Georgouras, Samuel S Zagarella, Geoffrey D Cains & Pamela J Brown. (2007) Systemic treatment of severe psoriasis. Australasian Journal of Dermatology 38:4, pages 171-180.
Crossref
Crossref
Grant W. Cannon. (1997) METHOTREXATE PULMONARY TOXICITY. Rheumatic Disease Clinics of North America 23:4, pages 917-937.
Crossref
Crossref
Joel M. Kremer, Graciela S. Alarcón, Michael E. Weinblatt, Mari V. Kaymakcian, Maurizio Macaluso, Grant W. Cannon, William R. Palmer, John S. Sundy, E. William St. Clair, Ronald W. Alexander, G. J. Walker Smith & Constantine A. Axiotis. (2005) Clinical, laboratory, radiographic, and histopathologic features of methotrexate‐associated lung injury in patients with rheumatoid arthritis. A multicenter study with literature review. Arthritis & Rheumatism 40:10, pages 1829-1837.
Crossref
Crossref
Agnes M.Th. Boerbooms, Pit J.S.M. Kerstens, Jos W.A. van Loenhout, Jan Mulder & Leo B.A. van de Putte. (1995) Infections during low-dose methotrexate treatmentin rheumatoid arthritis. Seminars in Arthritis and Rheumatism 24:6, pages 411-421.
Crossref
Crossref
Ferdinand Aglas, Franz Rainer, Josef Hermann, Judith Gretler, Elisabeth HüTtl, Wolfgang Domej & Guenter J. Krejs. (1995) Interstitial pneumonia due to cytomegalovirus following low-dose methotrexate treatment for rheumatoid arthritis. Arthritis & Rheumatism 38:2, pages 291-292.
Crossref
Crossref